Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS)

Sai Krishna C Korada1, Di Zhao2, Martin Tibuakuu3

  • 1Northeast Ohio Medical University, Rootstown, OH, USA.

Atherosclerosis
|September 10, 2017
PubMed

Insights

Frailty is linked to coronary atherosclerosis in HIV-uninfected men but not in HIV-infected men. Further research is needed to understand these differences and potential interventions for cardiovascular health.

Area of Science:

  • Gerontology
  • Cardiology
  • Infectious Diseases (HIV/AIDS)

Background:

  • Frailty and cardiovascular disease share common risk factors.
  • Understanding the independent association between frailty and subclinical coronary atherosclerosis is crucial.
  • Investigating potential differences in this association based on HIV-serostatus is important.

Purpose of the Study:

  • To evaluate if frailty is independently associated with subclinical coronary atherosclerosis.
  • To determine if the relationship between frailty and coronary atherosclerosis differs between HIV-uninfected and HIV-infected individuals.

Main Methods:

  • Study included 976 male participants from the Multicenter AIDS Cohort Study (62% HIV-infected).
  • Frailty assessed using 5 criteria (weakness, slowness, weight loss, exhaustion, low physical activity).
  • Subclinical coronary atherosclerosis evaluated using coronary artery calcium (CAC) and coronary CT angiography (CCTA) for plaque scoring (TPS, MPS, NCPS).

Main Results:

  • Frailty was more prevalent in HIV-infected men (14.3%) compared to HIV-uninfected men (7.5%).
  • Frailty was associated with coronary artery calcium (CAC>0), total plaque score (TPS>0), and mixed plaque score (MPS>0) in HIV-uninfected men after adjustments.
  • No significant association between frailty and subclinical coronary atherosclerosis was observed in HIV-infected men.

Conclusions:

  • Frailty is independently associated with subclinical coronary atherosclerosis in HIV-uninfected men.
  • This association was not found in HIV-infected men, suggesting a potential difference based on HIV status.
  • Further research is warranted to explore the underlying mechanisms and the impact of frailty interventions on cardiovascular outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
452
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
695
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
605
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K